Clinical Marker of Platelet Hyperreactivity in Diabetes Mellitus.
10.4093/dmj.2013.37.6.423
- Author:
Jin Hwa KIM
1
;
Hak Yeon BAE
;
Sang Yong KIM
Author Information
1. Department of Endocrinology and Metabolism, Chosun University Hospital, Chosun University School of Medicine, Gwangju, Korea. diabetes@chosun.ac.kr
- Publication Type:Review
- Keywords:
Blood platelets;
Diabetes mellitus;
Hyperreactivity;
Marker
- MeSH:
Biomarkers*;
Blood Platelets*;
Diabetes Mellitus*;
Fibrinolysis;
Humans;
Mortality
- From:Diabetes & Metabolism Journal
2013;37(6):423-428
- CountryRepublic of Korea
- Language:English
-
Abstract:
Atherothrombotic complications are important causes of morbidity and mortality in diabetic patients. Diabetes has been considered to be a prothrombotic status. Several factors contribute to the prothrombotic condition, such as increasing coagulation, impaired fibrinolysis, endothelial dysfunction, and platelet hyperreactivity. Among the factors that contribute to the prothrombotic status in diabetes, altered platelet function plays a crucial role. Although understanding platelet function abnormalities in diabetes still remains as a challenge, more attention should be focused on platelet function for effective management and the prediction of atherothrombotic events in diabetic patients. This review will provide an overview on the current status of knowledge of platelet function abnormalities and clinical marker of platelet hyperreactivity in patients with diabetes.
